MB Venture Partners

About MB Venture Partners

MB Venture Partners is a Memphis, Tennessee-based venture capital firm, founded in 2001, that provides capital and strategic direction to life science companies. It invests primarily in medical device start-ups at all stages of development, with seed and early-stage financings as its core. Beyond funding, it has been the largest sponsor and host of the Musculoskeletal New Ventures Conference for more than 20 years, connecting entrepreneurs, scientists, investors, and business development executives. It also co-founded the ZeroTo510 accelerator for medical device and healthtech start-ups. It has a special interest in product solutions for musculoskeletal disease, including orthopedics, spine, and tissue repair. Current portfolio companies include Cast21, Convey, SpineWave, SweetBio, and Lineus Medical, and strategic acquirers have included Johnson & Johnson, Medtronic, Smith+Nephew, Zimmer Biomet, and Wright Medical. MB invests in musculoskeletal ideas across the United States, and in non-musculoskeletal opportunities in the Southeast or Midwest, with selective later-stage financings. It pairs capital with board-level guidance and strategic introductions to the medical device industry.
People
  • Gary Stevenson, Managing Partner